Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis
Clinical trial NCT07055724 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07055724
- Sponsor
- Nanjing IASO Biotechnology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-06-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.